The Snowberry product, officially called ‘New Radiance Face Serum’, has been developed through a four-year research programme in conjunction with the School of Pharmacy at the University of Auckland.

The 8-week trial showed that, in a head-to-head comparison with USA market-leader Strivectin, the serum developed by Snowberry was 31.6% better at reducing wrinkle volume.

Following the trial, Snowberry has been invited to present the product at the World Congress of Dermatology in Vancouver in June.

The makers of the product say that, unlike most anti-aging skin care brands, Snowberry’s claims can be supported scientifically.

“In a market where luxury brands can cost up to a $1,000 but without any scientific proof of effectiveness,” says Snowberry Founder Soraya Hendesi, “women everywhere [can] have the benefits of a serum that is scientifically proven, at an affordable price”.

Hendesi says that it’s uncommon for cosmetic pharmaceuticals to submit to gold-standard third-party trials, with many opting to perform much less rigorous internal trials of their own.